Silk Road Medical Inc. said certain shareholders priced their sale of 4.2 million common shares of the company at $39.50 per share.
The secondary offering was upsized from the previous offering size of 3.5 million common shares. The 30-day option for the underwriters to purchase additional shares was also upsized to 630,000 common shares from 525,000 common shares.
The offering is expected to close Aug. 13.
J.P. Morgan Securities LLC and BofA Merrill Lynch are acting as joint book-running managers for the offering, while BMO Capital Markets and Stifel are acting as co-managers.
Silk Road is a medical device company focused on reducing the risk of stroke.